Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes

Adverse drug reactions (ADRs) are a major cause of hospital admissions, but recent data on the incidence and clinical characteristics of ADRs which occur following hospital admission, are lacking. Patients admitted to twelve wards over a six-month period in 2005 were assessed for ADRs throughout their admission. Suspected ADRs were recorded and analysed for causality, severity and avoidability and whether they increased the length of stay. Multivariable analysis was undertaken to identify the risk factors for ADRs. The 5% significance level was used when assessing factors for inclusion in multivariable models. Out of the 3695 patient episodes assessed for ADRs, 545 (14.7%, 95% CI 13.6–15.9%) experienced one or more ADRs. Half of ADRs were definitely or possibly avoidable. The patients experiencing ADRs were more likely to be older, female, taking a larger number of medicines, and had a longer length of stay than those without ADRs. However, the only significant predictor of ADRs, from the multivariable analysis of a representative sample of patients, was the number of medicines taken by the patient with each additional medication multiplying the hazard of an ADR episode by 1.14 (95% CI 1.09, 1.20). ADRs directly increased length of stay in 147 (26.8%) patients. The drugs most frequently associated with ADRs were diuretics, opioid analgesics, and anticoagulants. In conclusion, approximately one in seven hospital in-patients experience an ADR, which is a significant cause of morbidity, increasing the length of stay of patients by an average of 0.25 days/patient admission episode. The overall burden of ADRs on hospitals is high, and effective intervention strategies are urgently needed to reduce this burden.

[1]  A. Wilson.  The British National Formulary. , 1963, The Practitioner.

[2]  L. Cluff,et al.  EPIDEMIOLOGICAL STUDIES OF ADVERSE DRUG REACTIONS. , 1965, American journal of public health and the nation's health.

[3]  J W Smith,et al.  Studies on the epidemiology of adverse drug reactions. II. An evaluation of penicillin allergy. , 1966, The New England journal of medicine.

[4]  L. Cluff,et al.  Studies on the epidemiology of adverse drug reactions. V. Clinical factors influencing susceptibility. , 1966, Annals of internal medicine.

[5]  R. Ogilvie,et al.  Adverse drug reactions during hospitalization. , 1967, Canadian Medical Association journal.

[6]  N Hurwitz,et al.  Intensive Hospital Monitoring of Adverse Reactions to Drugs , 1969, British medical journal.

[7]  J. McCulloch,et al.  CHAPTER 7 – Implications for Prevention , 1972 .

[8]  P. Talwar.  Developing indices of nutritional level from anthropometric measurements on women and young children. , 1975, American journal of public health.

[9]  D. Davies,et al.  Textbook of Adverse Drug Reactions , 1992, Annals of Internal Medicine.

[10]  M. Rawlins.  Pathogenesis of adverse drug reactions , 1977 .

[11]  D. Greenblatt,et al.  A method for estimating the probability of adverse drug reactions , 1981, Clinical pharmacology and therapeutics.

[12]  J. W. Souther,et al.  What to report , 1985, IEEE Transactions on Professional Communication.

[13]  S. Roy,et al.  Adverse drug reactions: an investigation on an acute geriatric ward. , 1986, Age and ageing.

[14]  J. Hallas,et al.  Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention , 1990, Journal of internal medicine.

[15]  Roberto Bernabei,et al.  Is Age an Independent Risk Factor of Adverse Drug Reactions in Hospitalized Medical Patients?* , 1991, Journal of the American Geriatrics Society.

[16]  P. Schneider,et al.  Preventability and severity assessment in reporting adverse drug reactions. , 1992, American journal of hospital pharmacy.

[17]  R S Evans,et al.  Preventing Adverse Drug Events in Hospitalized Patients , 1994, The Annals of pharmacotherapy.

[18]  F. Gribnau,et al.  Drug use and adverse drug reactions in 105 elderly patients admitted to a general medical ward. , 1995, The Netherlands journal of medicine.

[19]  A. B. Prasad,et al.  British National Formulary , 1994 .

[20]  N. Laird,et al.  Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention , 1995 .

[21]  N. Laird,et al.  Incidence of adverse drug events and potential adverse drug events , 1995 .

[22]  D. Classen,et al.  Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. , 1997, JAMA.

[23]  D. Bates,et al.  The Costs of Adverse Drug Events in Hospitalized Patients , 1997 .

[24]  N. Moore,et al.  Frequency and cost of serious adverse drug reactions in a department of general medicine. , 1998, British journal of clinical pharmacology.

[25]  J. Buechner.  Adverse drug reactions in hospital patients. , 1998, Medicine and health, Rhode Island.

[26]  C. Simmons,et al.  ADVERSE DRUG REACTIONS : CAN WE REDUCE THE RISK? , 1998 .

[27]  P. Corey,et al.  Incidence of Adverse Drug Reactions in Hospitalized Patients , 2012 .

[28]  G. Kravitz,et al.  Adverse drug reactions in hospitalized patients. , 1998, JAMA.

[29]  R. Raschke,et al.  A computer alert system to prevent injury from adverse drug events: development and evaluation in a community teaching hospital. , 1998, JAMA.

[30]  K. Hui.  Adverse drug reactions in hospitalized patients. , 1998, JAMA.

[31]  D. Bates,et al.  Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. , 1999, JAMA.

[32]  Jason Lazarou,et al.  Incidence of Adverse Drug Reactions in Hospitalized Patients , 1999 .

[33]  I. Edwards,et al.  Adverse drug reactions: definitions, diagnosis, and management , 2000, The Lancet.

[34]  D. Suh,et al.  Clinical and Economic Impact of Adverse Drug Reactions in Hospitalized Patients , 2000, The Annals of pharmacotherapy.

[35]  I. Olkin,et al.  Adverse drug reactions in hospitalized patients: A critique of a meta-analysis. , 2000, MedGenMed : Medscape general medicine.

[36]  Helen Brown,et al.  Applied Mixed Models in Medicine , 2000, Technometrics.

[37]  J. Edwards,et al.  Extra Adverse drug reactions in hospital patients A systematic review of the prospective and retrospective studies , 2002 .

[38]  C. Vincent,et al.  Causes of prescribing errors in hospital inpatients: a prospective study , 2002, The Lancet.

[39]  C. Poole,et al.  Preventable Drug-Related Hospital Admissions , 2002, The Annals of pharmacotherapy.

[40]  M. Pirmohamed,et al.  Monitoring drug treatment , 2003, BMJ : British Medical Journal.

[41]  R E Ferner,et al.  Joining the DoTS: new approach to classifying adverse drug reactions , 2003, BMJ : British Medical Journal.

[42]  A. Avery,et al.  Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study , 2003, Quality & safety in health care.

[43]  Michael J. Peters,et al.  Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. , 2003, Archives of internal medicine.

[44]  E. Hahn,et al.  Implementation of a computer‐assisted monitoring system for the detection of adverse drug reactions in gastroenterology , 2004, Alimentary pharmacology & therapeutics.

[45]  P. Bemt.  Risk factors for the development of adverse drug events in hospitalised patients , 2004 .

[46]  A. W. Lenderink,et al.  Risk factors for the development of adverse drug events in hospitalized patients , 2000, Pharmacy World and Science.

[47]  M. Pirmohamed,et al.  Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.

[48]  D. Lawson,et al.  Risk factors for adverse drug reactions — epidemiological approaches , 1990, European Journal of Clinical Pharmacology.

[49]  I. Heineck,et al.  Adverse drug reactions: a cohort study in internal medicine units at a university hospital , 2006, European Journal of Clinical Pharmacology.

[50]  M Pirmohamed,et al.  Adverse drug reactions in hospital in‐patients: a pilot study , 2006, Journal of clinical pharmacy and therapeutics.

[51]  Border Ireland,et al.  Chartered Institute of Public Finance and Accountancy (CIPFA) , 2006 .

[52]  L. Boothby,et al.  Analysis of adverse drug reactions for preventability , 2007, International journal of clinical practice.

[53]  Munir Pirmohamed,et al.  Adverse drug reactions in hospitals: a narrative review. , 2007, Current drug safety.

[54]  Henrik Druid,et al.  Incidence of fatal adverse drug reactions: a population based study. , 2008, British journal of clinical pharmacology.

[55]  Jelena Savović,et al.  Methods for Causality Assessment of Adverse Drug Reactions , 2008, Drug safety.